Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

6
(from Reference Citation Analysis)

Article PDFs (1)

Cited by > 0 (2)

Searched Name

Ritonavir/supply & distribution

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number	Citation Analysis
1	Usher AD. The global COVID-19 treatment divide. Lancet 2022;399:779-782. [PMID: 35219388 PMCID: PMC8871493 DOI: 10.1016/s0140-6736(22)00372-5] [Citation(s) in RCA: 26] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Abstract Collapse Key Words Collapse MESH Headings COVID-19 Testing/standards COVID-19 Testing/statistics & numerical data Developing Countries Drug Combinations Global Health Health Services Accessibility Humans Lactams/supply & distribution Lactams/therapeutic use Leucine/supply & distribution Leucine/therapeutic use Nitriles/supply & distribution Nitriles/therapeutic use Proline/supply & distribution Proline/therapeutic use Ritonavir/supply & distribution Ritonavir/therapeutic use COVID-19 Drug Treatment Collapse Grants Collapse Affiliation(s) Collapse
2	Cawthorne P, Ford N, Wilson D, Kijtiwatchakul K, Purahong V, Tianudom N, Nacapew S. Access to drugs: the case of Abbott in Thailand. The Lancet Infectious Diseases 2007;7:373-4. [PMID: 17521589 DOI: 10.1016/s1473-3099(07)70118-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Abstract Collapse Key Words Collapse MESH Headings Drug Approval/legislation & jurisprudence Drug Combinations Drug Industry/economics Drug Industry/legislation & jurisprudence Drug and Narcotic Control/legislation & jurisprudence HIV Protease Inhibitors/economics HIV Protease Inhibitors/supply & distribution Health Services Accessibility/legislation & jurisprudence Humans Lopinavir Patents as Topic/legislation & jurisprudence Pyrimidinones/economics Pyrimidinones/supply & distribution Ritonavir/economics Ritonavir/supply & distribution Thailand Collapse Grants Collapse Affiliation(s) Collapse
3	Abbott expands low cost Kaletra. AIDS Patient Care STDS 2006;20:731-2. [PMID: 17083155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/12/2023] Open Abstract Collapse Key Words Collapse MESH Headings Developing Countries Drug Industry HIV Infections/drug therapy HIV Infections/economics HIV Protease Inhibitors/economics HIV Protease Inhibitors/supply & distribution Humans Lopinavir Private Sector Pyrimidinones/economics Pyrimidinones/supply & distribution Ritonavir/economics Ritonavir/supply & distribution Collapse Grants Collapse Affiliation(s) Collapse
4	Nau JY. [When Doctors Without Borders writes to Miles White, chairman of Abbott Laboratories]. Rev Med Suisse 2006;2:882. [PMID: 16646375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/08/2023] Abstract Collapse Key Words Collapse MESH Headings Acquired Immunodeficiency Syndrome/drug therapy Developing Countries Drug Combinations Drug Industry/ethics HIV Protease Inhibitors/supply & distribution Humans International Agencies Lopinavir Pyrimidinones/supply & distribution Ritonavir/supply & distribution Collapse Grants Collapse Affiliation(s) Collapse
5	Reformulated ritonavir. AIDS Patient Care STDS 1999;13:754. [PMID: 10743543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023] Open Abstract Collapse Key Words Collapse MESH Headings Capsules Chemistry, Pharmaceutical Drug Approval Gels HIV Protease Inhibitors/chemistry HIV Protease Inhibitors/supply & distribution Humans Ritonavir/chemistry Ritonavir/supply & distribution United States United States Food and Drug Administration Collapse Grants Collapse Affiliation(s) Collapse
6	James JS. Ritonavir capsule manufacturing problems will require switch to liquid formulation. AIDS Treat News 1998:1, 5. [PMID: 11365685] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/16/2023] Abstract Collapse Key Words Collapse MESH Headings Capsules Drug Storage HIV Infections/drug therapy HIV Protease Inhibitors/administration & dosage HIV Protease Inhibitors/supply & distribution Humans Ritonavir/administration & dosage Ritonavir/supply & distribution Solutions Collapse Grants Collapse Affiliation(s) Collapse